NEWS
Adequan® i.m. sponsors Road to the Triple Crown
Posted: Wednesday, March 10, 2010 4:58 PM
The prep season is under way for contenders headed to the 2010 Triple Crown, and Thoroughbred Times will keep racing fans informed of all races, news, and developments through its Road to the Triple Crown website sponsored by Adequan® i.m.
“The Triple Crown represents some of the most talented, athletic animals in the racing world. The wear and tear on these horses’ joints from the high demands of this sport makes these horses ideal candidates for Adequan® i.m.” said Allyn Mann, senior manager, Animal Health Division for Luitpold Pharmaceuticals, Inc., the manufacturer of Adequan.
Adequan® i.m. (polysulfated glycosaminoglycan) is pleased to sponsor The Road to the Triple Crown and encourages trainers and horse owners to view their joint health video at: www.adequan.com.
The Road to the Triple Crown website features profiles of contenders, news on contenders, coverage of prep races, links to biographies of leading trainers, jockeys, owners, and breeders, history of the Triple Crown, in-depth statistics, and more.
The Triple Crown begins with the Kentucky Derby Presented by Yum! Brands (G1) on May 1 at Churchill Downs, continues with the Preakness Stakes (G1) on May 15 at Pimlico Race Course, and concludes with the Belmont Stakes on June 5 at Belmont Park.
For more information, contact Tom Law at (859) 260-9800 ext. 125
About Thoroughbred Times Co.
Thoroughbred Times Company publishes the Thoroughbred Times, a weekly newsmagazine for owners, breeders, trainers, and racing enthusiasts worldwide. Thoroughbred Times also publishes an annual Stallion Directory, the Buyer’s Guides for auctions, an annual Auction Review, the daily electronic newsletter Thoroughbred Times TODAY, and maintains a comprehensive website at http://www.thoroughbredtimes.com.
About Luitpold
Luitpold Animal Health, based in Shirley, New York, markets Adequan® i.m., Adequan® i.a. and Equiphen® Paste for horses. The company is committed to advancing the cause of equine health. Adequan® i.m.(polysulfated glycosaminoglycan) is the only FDA-approved treatment for degenerative joint disease (DJD) clinically proven to relieve the pain and symptoms of osteoarthritis and stimulate the natural “wear and repair” cycle within the joint. This injectible treatment works by blocking the damaging enzymes as they form, relieving pain of inflammation, improving lubrication in the joints, and inhibiting degeneration before cartilage damage can continue. For more information about products from Luitpold Animal Health, visit www.adequan.com or call 1-800-458-0163. Adequan® and Equiphen® are registered trademarks of Luitpold Pharmaceuticals, Inc.
